ClinicalTrials.gg
Enrolling by invitationNCT06522321Updated Jul 30, 2024

Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone

A Phase 2 interventional study of i-PRF and FDBA in Bone Density Increased, sponsored by Krishnadevaraya College of Dental Sciences & Hospital. Enrolling by invitation at 1 site in India. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-30.

Sponsored by Krishnadevaraya College of Dental Sciences & Hospital · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Aug 2024, 2 years 2 months ago, but the record still lists the study as enrolling by invitation.
  • Registered 1 year after the study started (first participant enrolled Jul 2023, registered Jul 2024).
Phase
Phase 2
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The present study is a human, prospective, parallel, randomised controlled clinical trial conducted for radiographic assessment of bone dimension around immediate implants with FDBA and I-PRF vs FDBA Alone The trial is in accordance with the Consolidated Standards of Reporting Trials (CONSORT) criteria, 2010.

Read the detailed description

Twenty healthy individuals satisfying the inclusion and exclusion criteria were recruited for the study. A detailed, thorough medical and dental history was obtained and each patient was subjected to comprehensive clinical and radiological examination. All patients were informed about the nature of the study, the surgical procedure involved, potential benefits and risks associated with the surgical procedure and written informed consent were obtained from all patients. All the patients were treated with immediate implants in endodontically and periodontically compromised sites. FDBA graft along with I-PRF is combined to form a sticky bone, this stable element is placed around the implants where bone is compromised.

The clinical and radiographic parameters were recorded at baseline, three months and six months postoperatively

02

Conditions studied

  • Bone Density Increased

Keywords

  • Injectable platelet rich fibrin
  • bone dimensions
  • freeze dried bone allograft
03

In context

Lead sponsor

Krishnadevaraya College of Dental Sciences & Hospital is the lead sponsor of 51 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients between 18-55 years of age.
  2. Presence of non-restorable single rooted teeth (maxillary or mandibular) due to trauma, caries, root resorption, root fracture, endodontic or periodontal failure.
  3. Grade I or Grade II extraction socket according to El Chaar et al 2016.
  4. Good oral hygiene.
  5. Good patient compliance.

Exclusion criteria

Exclusion Criteria:

  1. Systemic complications (uncontrolled diabetes and severe cardiovascular or infectious diseases).
  2. Intravenous and oral bisphosphonate therapy.
  3. Patients who are psychologically unable to participate.
  4. Pregnant patients, patients with bone diseases and patients on chemotherapy or radiotherapy, alcohol or drug abuse.
  5. Patients with hemorrhagic disorders.
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Radiographic Assessment of Bone Dimension Around Immediate with FDBA and i-PRF vs FDBA

    TEST GROUP: FDBA and I-PRF with immediate implant placement. Local anesthesia is given. Atraumatic extraction is done. I-PRF is prepared by centrifugation procedure. Osteotomy is done at the selected site after radiographic assessment. Immediate implant is placement along with I-PRF and FDBA. Suture is placed at the surgical site.

    Biological: i-PRF and FDBA

  • Experimental
    Radiographic Assessment of Bone Dimensions Around Immediate Implants With FDBA and I-PRF vs FDBA

    CONTROL GROUP: FDBA alone with immediate implant placement. Local anesthesia is given. Atraumatic extraction is done.Osteotomy is done at the selected site after radiographic assessment. Immediate implant is placement along with FDBA alone. Suture is placed at the surgical site.

    Biological: i-PRF and FDBA

Interventions

  • Biologicali-PRF and FDBA

    A mucoperiosteal flap will be raised and atraumatic extraction will be done. An immediate implant with FDBA and I-PRF (experimental group) will be placed according to the standard protocol. An immediate implant with FDBA( comparative group) will be placed according to the standard protocol . The surgical wound closure will be coapted with sutures

    Also known as: platelet rich fibrin and freeze dried bone

06

What researchers measure

Primary outcomes

  1. Bone fill

    Standard digital radiographs were taken at baseline, 3 months and 6 months by paralleling/long-cone technique. Radiographic images at all the time intervals were taken by using a metallic counting grid (IOPA film grid® , BlueDent, Chennai, India). The bone-fill was measured in square millimeters by point-counting the number of squares over newly developing radiopacities at different follow up periods. Squares that were half filled or unclear were not counted.

    Time frame: At baseline, 3 months and 6 months

  2. Bone dimensions

    The sites will be assessed vertically and horizontally by CBCT images taken at baseline and 6 months after the implant placement.

    Time frame: At baseline, 3 months and 6 months

  3. Bone density

    Bone mineral density is obtained by the CBCT (GENORAY (PAPAYA 3D premium operation software)

    Time frame: At baseline, 3 months and 6 months

  4. Marginal bone level

    distance between reference point(the implant shoulder) and the first marginal bone-to-implant contact level using standard digital radiographs

    Time frame: At baseline, 3 months and 6 months

  5. Early wound healing index

    SCORE 1: COMPLETE FLAP CLOSURE NO FIBRIN LINE IN THE INTERPROXIMAL AREA SCORE 2: COMPLETE FLAP CLOSURE FINE FIBRIN LINE IN THEINTERPROXIMAL AREA SCORE 3: COMPLETE FLAP CLOSURE FIBRIN CLOT IN THE INTERPROXIMAL AREA SCORE 4:INCOMPLETE FLAP CLOSURE PARTIAL NECROSIS OF THE INTERPROXIMAL AREA SCORE 5: INCOMPLETE FLAP CLOSURE COMPLETE NECROSIS OF THE INTERPROXIMAL AREA. SCORE 1: COMPLETE FLAP CLOSURE NO FIBRIN LINE IN THE INTERPROXIMAL AREA SCORE 2: COMPLETE FLAP CLOSURE FINE FIBRIN LINE IN THEINTERPROXIMAL AREA SCORE 3: COMPLETE FLAP CLOSURE FIBRIN CLOT IN THE INTERPROXIMAL AREA SCORE 4:INCOMPLETE FLAP CLOSURE PARTIAL NECROSIS OF THE INTERPROXIMAL AREA SCORE 5: INCOMPLETE FLAP CLOSURE COMPLETE NECROSIS OF THE INTERPROXIMAL AREA. Wachet et al wound healing index will be used for obtaining the healing index

    Time frame: At baseline, 3 months and 6 months

Secondary outcomes

  1. GINGIVAL INDEX

    The severity of gingivitis is scored on the mesiofacial and distofacial papillae, facial and lingual margin of selected teeth. A blunt instrument is used to assess the bleeding potential of tissues The index relies entirely on visual criteria of gingivitis and eliminates the use of probing or pressure to establish the presence or absence of bleeding.

    Time frame: 3 months and 6 months

  2. GINIVAL BLEEDING INDEX

    The gingival bleeding index of Ainamo J and Bay I was developed as an easy and suitable way for assessing a patient's progress in Plaque control. The presence or absence of gingival bleeding is determined by gentle probing of the gingival crevice with a periodontal probe. The appearance of bleeding within 10 seconds indicates a positive score, which is expressed as percentage of the total number of gingival margin examined.

    Time frame: 3 months and 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06522321
Lead sponsor
Krishnadevaraya College of Dental Sciences & Hospital
Responsible party
Dr Prabhuji MLV (HOD OF PERIODONTOLOGY, Krishnadevaraya College of Dental Sciences & Hospital) — Principal investigator
First posted
Jul 26, 2024
Start date
Jul 15, 2023
Primary completion
Aug 25, 2024 (estimated)
Completion
Oct 25, 2024 (estimated)
Last update
Jul 30, 2024

Study contacts

Dr Prabhuji MLV, MDS
study chair · PROFESSOR AND HOD

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion